Cargando…
A case of histoplasmosis in a patient with MDS/MPN-U
Autores principales: | Rastogi, Pulkit, Sharma, Prashant, Kumar, Narender, Rudramurthy, Shivaprakash M., Varma, Neelam, Varma, Subhash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054255/ https://www.ncbi.nlm.nih.gov/pubmed/27722134 http://dx.doi.org/10.5045/br.2016.51.3.206 |
Ejemplares similares
-
Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020) -
Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents
por: Duchmann, M, et al.
Publicado: (2017) -
The first case report of a patient with coexisting hemophilia B and Down syndrome
por: Rastogi, Pulkit, et al.
Publicado: (2017) -
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
por: Hebeda, Konnie M., et al.
Publicado: (2009) -
Recurrent bilateral adrenal infarction with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U): a case report
por: Hoshino, Yoshitomo, et al.
Publicado: (2023)